炎症性肠病患者的心脏代谢疾病:基于证据的综述
Krishneel Dutt1,2, Abhinav Vasudevan1,2, Alexander Hodge1,2,3
1Department of Gastroenterology and Hepatology, Eastern Health, Box Hill 3128, Victoria, Australia.
World journal of gastroenterology
|July 2, 2025
概括
代谢综合征和炎症性肠病 (IBD) 具有共同的风险因素,并且可能与生物相关. 早期识别IBD患者心脏代谢风险对于改善健康结果至关重要.
科学领域:
- 胃肠病学和心脏病学
- 代谢健康和炎症 代谢健康和炎症
背景情况:
- 代谢综合征是一种疾病集群 (中心脂肪,脂质不良,胰岛素抵抗,高血压),增加心脏代谢疾病的风险.
- 代谢综合征和炎症性肠病 (IBD) 的全球流行率上升与城市化,久坐的生活方式和饮食转变有关.
- 新出现的证据表明,IBD中的慢性胃肠道炎症与随后的心脏代谢障碍之间存在生物学联系.
研究的目的:
- 审查目前有关IBD和心脏代谢障碍的证据.
- 强调认识到IBD患者心脏代谢风险的重要性.
- 确定未来的研究方向来管理这些相互关联的条件.
主要方法:
- 对IBD和心脏代谢风险现有研究的文献综述.
- 分析了导致这两种疾病发病率上升的因素.
- 在克罗恩病和性结肠炎的比较研究中讨论不一致的发现.
主要成果:
- 共同的风险因素将代谢综合征和IBD联系在一起.
- 一个潜在的生物学途径将胃肠道炎症与心脏代谢疾病联系起来.
- 对比研究中不一致的发现凸显了控制混因素的必要性.
结论:
- 临床医生必须了解并评估IBD患者的心脏代谢风险.
- 旨在控制肠道炎症的治疗目标策略可能会改善IBD和心脏代谢结果.
- 需要进一步的研究来验证炎症控制对IBD的长期心脏代谢健康的影响.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Inflammatory Bowel Disease II: Crohn's Disease
399
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
399
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
277
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
277
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
208
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
208


